Patricia Bridget Mason N O v Graham Andrew Mason and Another

Ashley Mason (deceased) and his brother Graham Andrew Mason (first respondent) were members of L Mason Electrical CC (second respondent), holding 60% and 40% interests respectively. The deceased managed the CC's finances while Graham focused on technical/operational aspects. In 1999, the brothers entered an agreement providing that on death of either, the survivor would purchase the deceased's interest using proceeds from a life insurance policy, with clause 6.2 allowing the survivor to withhold amounts equal to any debt the deceased owed the CC. Ashley died on 25 April 2016. The policy proceeds were R4,779,372. Patricia Mason (Ashley's wife and executrix of his estate) claimed payment of this amount from Graham. Graham resisted, alleging that during his lifetime Ashley had misappropriated millions from the CC over approximately 15 years (2001-2016), which debt exceeded the policy proceeds. A forensic investigation by Derek Pearton revealed misappropriations totaling R7,406,139.97. The executrix raised a special plea of prescription, arguing that Graham's knowledge (actual or constructive) of the misappropriations should be attributed to the CC, thus only misappropriations in the three years before death (approximately R644,142.58) were not prescribed.

• Whether the debt owed by the deceased to the CC had prescribed under section 11 of the Prescription Act 68 of 1969
• Whether Graham Mason had actual or constructive knowledge of the misappropriation during the deceased's lifetime for purposes of section 12(3) of the Prescription Act
• Whether a member's knowledge could be attributed to the close corporation for purposes of prescription
• Whether the executrix should bear costs in her personal or representative capacity

1. The appeal was dismissed with costs, including costs of two counsel where employed. 2. The cross-appeal was dismissed (with no order as to its costs).

A creditor claiming the benefit of the exception in section 12(3) of the Prescription Act (delaying commencement of prescription until knowledge is acquired) will fail where the debtor proves that the creditor could have acquired knowledge of the debt by exercising reasonable care. However, the debtor bears the onus of proving this deemed or constructive knowledge. The mere fact that a member of a close corporation has fiduciary duties and statutory rights to access information is insufficient to establish constructive knowledge; there must be factual evidence that a reasonable person in that member's actual position would have exercised those rights to acquire knowledge of the wrongdoing. The assessment must be made objectively from the perspective of the creditor's actual circumstances at the relevant time, not with hindsight or based on hypothetical assumptions about how the creditor should have behaved. Where business operations involve clear role separation, trust-based relationships, and deliberate exclusion from certain functions, constructive knowledge will not readily be inferred from failure to investigate matters outside the creditor's designated responsibilities.

The Court noted that the corporate attribution issue (whether a member's knowledge can be attributed to a close corporation for prescription purposes) did not require determination given the failure to establish constructive knowledge on the facts. This left open for future determination the important question of whether and in what circumstances knowledge of one member of a CC should be attributed to the corporation itself. The Court also observed that red flags are easily identified in hindsight but the appropriate perspective is that of the reasonable person at the relevant time, not retrospectively. The judgment contains implicit commentary on the nature of family businesses and the reasonable expectations regarding trust and role division in such contexts. The Court also indicated that criticisms of case management do not warrant interference with costs orders on appeal, and that executors acting bona fide in their representative capacity to protect estate interests should not ordinarily be held personally liable for costs even where unsuccessful.

This case provides important guidance on the application of section 12(3) of the Prescription Act in the context of close corporations and fiduciary relationships. It clarifies that: (1) mere legal capacity or statutory rights to acquire information do not automatically establish constructive knowledge for prescription purposes; (2) factual evidence is required to show that a reasonable person in the creditor's position would have taken steps to acquire knowledge; (3) the test is whether the creditor "could have acquired" knowledge "by exercising reasonable care", which must be assessed objectively from the creditor's actual position, not hypothetical assumptions; (4) business relationships based on trust and clear role separation may justify non-involvement in certain aspects without triggering constructive knowledge; (5) sophisticated concealment of wrongdoing requiring forensic investigation weighs against a finding of constructive knowledge; and (6) hindsight cannot be used to identify "red flags" that were not objectively apparent at the relevant time. The judgment also confirms that in estate litigation, the default position is that costs are borne by the estate in the executrix's representative capacity unless special circumstances justify personal liability.